{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:26:28Z","timestamp":1789079188656,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2003,7,29]],"date-time":"2003-07-29T00:00:00Z","timestamp":1059436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,7,29]],"date-time":"2003-07-29T00:00:00Z","timestamp":1059436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,8,1]]},"DOI":"10.1038\/sj.leu.2403004","type":"journal-article","created":{"date-parts":[[2003,7,29]],"date-time":"2003-07-29T09:12:40Z","timestamp":1059469960000},"page":"1636-1642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells"],"prefix":"10.1038","volume":"17","author":[{"given":"A","family":"Falanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Barbui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,7,29]]},"reference":[{"key":"BF2403004_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0014-2999(93)90864-E","volume":"238","author":"G Bianchi","year":"1993","unstructured":"Bianchi G, Barone D, Panzarotti E, Tettamanti R, Porta R, Moltrasio D et al. Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist. Eur J Pharmacol 1993; 238: 327\u2013334.","journal-title":"Eur J Pharmacol"},{"issue":"Suppl. 1","key":"BF2403004_CR2","first-page":"29","volume":"22","author":"C Cimminiello","year":"1996","unstructured":"Cimminiello C . Clinical trials with defibrotide in vascular disorders. Semin Thromb Hemost 1996; 22 (Suppl. 1): 29\u201334.","journal-title":"Semin Thromb Hemost"},{"key":"BF2403004_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1055\/s-0037-1613890","volume":"83","author":"F Violi","year":"2000","unstructured":"Violi F, Marubini E, Coccheri S, Nenci GG . Improvement of walking distance by defibrotide in patients with intermittent claudication. Results of randomized, placebo-controlled study. Thromb Haemost 2000; 83: 672\u2013677.","journal-title":"Thromb Haemost"},{"key":"BF2403004_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/00003495-199345020-00007","volume":"45","author":"KJ Palmer","year":"1993","unstructured":"Palmer KJ, Goa KL . Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs 1993; 45: 259\u2013294.","journal-title":"Drugs"},{"key":"BF2403004_CR5","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI . The syndrome of hepatic veno-occlusive disease after bone marrow transplantation. Blood 1995; 85: 3005\u20133020.","journal-title":"Blood"},{"key":"BF2403004_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000046590","volume":"106","author":"PG Richardson","year":"2001","unstructured":"Richardson PG, Guinan EC . Hepatic veno-occlusive disease following hematopoietic stem cell transplantation. Acta Haematol 2001; 106: 57\u201368.","journal-title":"Acta Haematol"},{"key":"BF2403004_CR7","first-page":"737","volume":"92","author":"PG Richardson","year":"1998","unstructured":"Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737\u2013744.","journal-title":"Blood"},{"key":"BF2403004_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","volume":"111","author":"R Chopra","year":"2000","unstructured":"Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C et al. Defibrotide for the treatment of hepatic veno occlusive disease: results of the European compassionate-use study. Br J Haematol 2000; 111: 1122\u20131129.","journal-title":"Br J Haematol"},{"key":"BF2403004_CR9","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D et al. Multi-institutional use of defibrotide in 88 patients post stem cell transplant with severe veno-occlusive disease and multi-system organ failure. Response without significant toxicity in a high risk population and factors predictive of outcome. Blood 2002; 100: 4337\u20134343.","journal-title":"Blood"},{"key":"BF2403004_CR10","doi-asserted-by":"publisher","first-page":"V215","DOI":"10.1016\/S0049-3848(01)00285-7","volume":"102","author":"FR Rickles","year":"2001","unstructured":"Rickles FR, Falanga A . Molecular basis of the relationship between thrombosis and cancer. Thromb Res 2001; 102: V215\u2013V224.","journal-title":"Thromb Res"},{"issue":"Suppl. 1","key":"BF2403004_CR11","first-page":"1","volume":"31","author":"A Falanga","year":"2001","unstructured":"Falanga A . Tumor cell prothrombotic properties. Haemostasis 2001; 31 (Suppl. 1): 1\u20134.","journal-title":"Haemostasis"},{"key":"BF2403004_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-2007-994915","volume":"25","author":"AY Lee","year":"1999","unstructured":"Lee AY, Levine MN . The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Haemost 1999; 25: 137\u2013145.","journal-title":"Semin Thromb Haemost"},{"key":"BF2403004_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0002-9343(88)90420-2","volume":"84","author":"F Cozzolino","year":"1988","unstructured":"Cozzolino F, Torcia M, Miliani A, Carossino AM, Giordani R, Cinotti S et al. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. Am J Med 1988; 84: 240\u2013250.","journal-title":"Am J Med"},{"key":"BF2403004_CR14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1182\/blood.V87.2.613.bloodjournal872613","volume":"87","author":"A Falanga","year":"1996","unstructured":"Falanga A, Marchetti M, Giovanelli S, Barbui T . All-trans retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocitic leukemia-derived cell line (NB4). Blood 1996; 87: 613\u2013617.","journal-title":"Blood"},{"key":"BF2403004_CR15","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood.V91.9.3093","volume":"91","author":"T Barbui","year":"1988","unstructured":"Barbui T, Finazzi G, Falanga A . The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 1988; 91: 3093\u20133102.","journal-title":"Blood"},{"key":"BF2403004_CR16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/01.ATV.17.7.1193","volume":"17","author":"C Garlanda","year":"1997","unstructured":"Garlanda C, Dejana E . Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 1997; 17: 1193\u20131202.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF2403004_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000046589","volume":"106","author":"HC Kwaan","year":"2001","unstructured":"Kwaan HC, Gordon LI . Thrombotic microangiopathy in the cancer patient. Acta Haematol 2001; 106: 57\u201368.","journal-title":"Acta Haematol"},{"key":"BF2403004_CR18","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/0306-3623(94)90363-8","volume":"25","author":"N Hizal","year":"1994","unstructured":"Hizal N, Bilsel S, Emerk K . Investigation of the fibrinolytic activity of defibrotide fractions. Gen Pharmacol 1994; 25: 1617\u20131620.","journal-title":"Gen Pharmacol"},{"key":"BF2403004_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0038-1642468","volume":"71","author":"Q Zhou","year":"1994","unstructured":"Zhou Q, Chu X, Ruan C . Defibrotide stimulates the expression of thrombomodulin in human endothelial cells. Thromb Haemost 1994; 71: 507\u2013510.","journal-title":"Thromb Haemost"},{"key":"BF2403004_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/1523-1747.ep12613748","volume":"99","author":"EW Ades","year":"1992","unstructured":"Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99: 683\u2013690.","journal-title":"J Invest Dermatol"},{"key":"BF2403004_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1012259529167","volume":"4","author":"D Bouis","year":"2001","unstructured":"Bouis D, Hospers GA, Meijer C, Molema G, Mulder NH . Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related reasearch. Angiogenesis 2001; 4: 91\u2013102.","journal-title":"Angiogenesis"},{"key":"BF2403004_CR22","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI107470","volume":"52","author":"EA Jaffe","year":"1973","unstructured":"Jaffe EA, Nachman RL, Becker CG, Minick CR . Culture of human endothelial cells derived from umbilical cord veins. Identification of morphology and immunologic criteria. J Clin Invest 1973; 52: 2745\u20132756.","journal-title":"J Clin Invest"},{"key":"BF2403004_CR23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood.V76.5.930.930","volume":"76","author":"WL Chandler","year":"1990","unstructured":"Chandler WL, Trimble SL, Loo SC, Mornin D . Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA\/PAI-1 complex in plasma. Blood 1990; 76: 930\u2013937.","journal-title":"Blood"},{"key":"BF2403004_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ajh.10072","volume":"69","author":"O Bairey","year":"2002","unstructured":"Bairey O, Kirgner I, Yakobi M, Hamdan A, Ben-Ari Z, Shaklai M . Clinical severe hepatic veno-occlusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide. Am J Hematol 2002; 69: 281\u2013284.","journal-title":"Am J Hematol"},{"key":"BF2403004_CR25","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1097\/00007890-200110150-00009","volume":"72","author":"E Mor","year":"2001","unstructured":"Mor E, Pappo O, Bar-Nathan N, Shaharabani E, Shapira Z, Tur-Kaspa R et al. Defibrotide for the treatment of veno-occlusive disease after liver transplantation. Transplantation 2001; 72: 1237\u20131240.","journal-title":"Transplantation"},{"key":"BF2403004_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF03258468","volume":"7","author":"P Ferrari","year":"1994","unstructured":"Ferrari P, Clerici G, Gussoni G, Nazzari M . Defibrotide versus placebo in the treatment of intermittent claudication. A meta-analysis. Drug Invest 1994; 7:157\u2013160.","journal-title":"Drug Invest"},{"key":"BF2403004_CR27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00280122","volume":"42","author":"F Violi","year":"1992","unstructured":"Violi F, Ferro D, Saliola M, Quintarelli C, Basili S, Balsano F . Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance. Eur J Clin Pharmacol 1992; 42:379\u2013383.","journal-title":"Eur J Clin Pharmacol"},{"key":"BF2403004_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0049-3848(92)90241-2","volume":"65","author":"G Davi","year":"1992","unstructured":"Davi G, Catalano I, Belvedere M, Amato S, Mogavero A, Giammarresi C et al. Effects of defibrotide on fibrinolytic activity in diabetic patients with stable angina pectoris. Thromb Res 1992; 65:211\u2013220.","journal-title":"Thromb Res"},{"issue":"Suppl. 1","key":"BF2403004_CR29","first-page":"15","volume":"22","author":"FL Pasini","year":"1996","unstructured":"Pasini FL, Frigerio C, Capecchi PL, Ceccatelli L, Messa GL, Franchi M et al. Modulation of venous endothelial activity and transcellular calcium transport by defibrotide: the adenosine hypothesis. Semin Thromb Haemost 1996; 22 (Suppl. 1): 15\u201320.","journal-title":"Semin Thromb Haemost"},{"key":"BF2403004_CR30","first-page":"39","volume":"15","author":"DA Hoppensteadt","year":"1996","unstructured":"Hoppensteadt DA, Jeske W, Fareed J, Nicolaides AN . Physical and pharmacologic modulation of the vascular system as measured by the release of TFPI, and other mediators of antithrombotic actions. Int Angiol 1996; 15: 39\u201346.","journal-title":"Int Angiol"},{"key":"BF2403004_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/107602960100700308","volume":"7","author":"G Cella","year":"2001","unstructured":"Cella G, Sbarai A, Mazzaro G, Motta G, Carraro P, Andreozzi GM et al. Tissue factor pathway inhibitor release induced by defibrotide and heparins. Clin Appl Thromb Hemost 2001;7:225\u2013228.","journal-title":"Clin Appl Thromb Hemost"},{"key":"BF2403004_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0014-2999(87)90687-X","volume":"135","author":"F Berti","year":"1987","unstructured":"Berti F, Rossoni G, Omini C, Folco G, Daffonchio L, Vigano T et al. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart. Eur J Pharmacol 1987; 135: 375\u2013382.","journal-title":"Eur J Pharmacol"},{"issue":"Suppl. 1","key":"BF2403004_CR33","first-page":"21","volume":"22","author":"ON Ulutin","year":"1996","unstructured":"Ulutin ON, Balkuv-Ulutin S, Bezer-Goker B, Cizmeci G, Ferhanoglu B, Ozsoy Y et al. Effect of defibrotide on platelet function. Semin Thromb Hemost 1996; 22 (Suppl. 1): 21\u201324.","journal-title":"Semin Thromb Hemost"},{"key":"BF2403004_CR34","first-page":"399","volume":"9","author":"T Di Perri","year":"1987","unstructured":"Di Perri T, Laghi Pasini F, Capecchi PL, Beccatelli L, Pasqui AL, Orrico A . Defibrotide in vitro inhibits neutrophil activation by Ca++ involving mechanism. Int J Tissue Reaction 1987; 9: 399\u2013406.","journal-title":"Int J Tissue Reaction"},{"key":"BF2403004_CR35","first-page":"98","volume":"21","author":"F Cirillo","year":"1991","unstructured":"Cirillo F, Margaglione M, Vecchione G, Ames PR, Coppola A, Grandone E et al. In vitro inhibition by defibrotide of monocyte superoxide anion generation: a possible mechanism for the antithrombotic effect of a polydeoxyribonucleotide-derived drug. Haemostasis 1991; 21: 98\u2013105.","journal-title":"Haemostasis"},{"key":"BF2403004_CR36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1055\/s-0038-1648519","volume":"67","author":"V Evangelista","year":"1992","unstructured":"Evangelista V, Piccardoni P, de Gaetano G, Cerletti C . Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes. Thromb Haemost 1992;67:660\u2013664.","journal-title":"Thromb Haemost"},{"key":"BF2403004_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-2007-1000400","volume":"21","author":"R Abbate","year":"1995","unstructured":"Abbate R, Gori AM, Martini F, Attanasio M, Comeglio P, Giusti B et al. Defibrotide reduces monocyte PAI-2 and procoagulant activity. Semin Thromb Hemost 1995;21:245\u2013250.","journal-title":"Semin Thromb Hemost"},{"key":"BF2403004_CR38","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1182\/blood.V80.10.2668.2668","volume":"80","author":"DW Beelen","year":"1992","unstructured":"Beelen DW, Haralambie E, Brandt H, Linzenmeier G, Muller KD, Quabeck K et al. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood 1992; 80:2668\u20132676.","journal-title":"Blood"},{"key":"BF2403004_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2141.1995.tb05143.x","volume":"90","author":"A Blann","year":"1995","unstructured":"Blann A, Taberner DA . A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995; 90: 244\u2013248.","journal-title":"Br J Haematol"},{"key":"BF2403004_CR40","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1172\/JCI110945","volume":"71","author":"M Colucci","year":"1983","unstructured":"Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D . Cultured endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893\u20131896.","journal-title":"J Clin Invest"},{"key":"BF2403004_CR41","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1016\/S0021-9258(19)38739-3","volume":"265","author":"DC Crossman","year":"1990","unstructured":"Crossman DC, Carr DP, Tuddenhan EG, Pearson JD, McVey JH . The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265: 9782\u20139787.","journal-title":"J Biol Chem"},{"key":"BF2403004_CR42","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1161\/01.CIR.101.18.2144","volume":"101","author":"Y Yang","year":"2000","unstructured":"Yang Y, Loscalzo J . Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 2000; 101: 2144\u20132148.","journal-title":"Circulation"},{"key":"BF2403004_CR43","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","volume":"89","author":"C Salat","year":"1997","unstructured":"Salat C, Holler E, Kolb HJ, Reinhardt B, Pihusch R, Wilmanns W et al. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood 1997; 89: 2184\u20132188.","journal-title":"Blood"},{"key":"BF2403004_CR44","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1046\/j.1365-2141.2002.03748.x","volume":"118","author":"JH Lee","year":"2002","unstructured":"Lee JH, Lee KH, Lee JM, Kim S, Seol M, Park CJ, Chi HS, Kang W, Kim ST, Kim WK, Lee JS . Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide. Br J Haematol 2002; 118: 1087\u20131094.","journal-title":"Br J Haematol"},{"key":"BF2403004_CR45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1182\/blood.V100.1.334","volume":"100","author":"G Eissner","year":"2002","unstructured":"Eissner G, Multhoff G, Gerbitz A, Kirchner S, Bauer S, Haffner S et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood 2002; 100: 334\u2013340.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403004","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T10:17:25Z","timestamp":1704881845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,29]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8,1]]}},"alternative-id":["BF2403004"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403004","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,29]]},"assertion":[{"value":"23 January 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}